1.
|
Phase: Phase IV Type: Supportive care, Treatment Status: Completed Age: 15 to 70 Sponsor: Other Protocol IDs: OLSG-0401, NCT00162955
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Completed Age: 15 to 65 Sponsor: Other Protocol IDs: GMALL03, NCT00199004
|
|
3.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 to 45 Sponsor: Other Protocol IDs: 0501-37, NCT00352872
|
|
4.
|
Phase: Phase IV Type: Treatment Status: Completed Age: 18 to 70 Sponsor: Other Protocol IDs: 2006-003750-23, LINFOTARGAM, NCT00466258
|
|
5.
|
Phase: Phase IV Type: Treatment Status: Completed Age: 15 to 65 Sponsor: Other Protocol IDs: GMALL04, NCT00199017
|
|
6.
|
Phase: Phase IV Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: TaCyDexVMP7, NCT00652041
|
|
7.
|
Phase: Phase IV Type: Treatment Status: Completed Age: 18 to 75 Sponsor: Other Protocol IDs: CHOP-Z, NCT01418430
|
|
8.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: under 21 at relapse Sponsor: NCI Protocol IDs: POG-9410, POG-SIMAL-8
|
|
9.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: EST-3278
|
|
10.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: DFCI-75100
|
|
11.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: DFCI-75118
|
|
12.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-7841
|
|
13.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-7904
|
|
14.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-7922
|
|
15.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: EST-1583
|
|
16.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDA-DT-8102
|
|
17.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: under 65 Sponsor: Protocol IDs: WCCC-CO-7711R, NCI-D80-048-183
|
|
18.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: under 65 Sponsor: Protocol IDs: NCI-76-C-377A, NCI-MB-160A
|
|
19.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NCI-76-C-377B, NCI-MB-160B
|
|
20.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: 10 to 65 Sponsor: NCI Protocol IDs: NCI-80-C-45, NCI-SB-S9, NCI-T83-1103N, T83-1103
|
|
21.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: NCI-82-C-100
|
|
22.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: EST-1281
|
|
23.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: GITSG-8380
|
|
24.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: NCCTG-825251, NCCTG-82-52-51
|
|
25.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: under 70 Sponsor: Protocol IDs: UCCRC-3248, NCI-D81-014-080
|